452 related articles for article (PubMed ID: 17159504)
21. 15-Deoxy-Δ12,14-prostaglandin J2 induces PPARγ- and p53-independent apoptosis in rabbit synovial cells.
Sakaba Y; Awata H; Morisugi T; Kawakami T; Sakudo A; Tanaka Y
Prostaglandins Other Lipid Mediat; 2014 Jun; 109-111():1-13. PubMed ID: 24680891
[TBL] [Abstract][Full Text] [Related]
22. The effect of peroxisome proliferator-activated receptor-gamma ligand on urological cancer cells.
Yoshimura R; Matsuyama M; Hase T; Tsuchida K; Kuratsukuri K; Kawahito Y; Sano H; Segawa Y; Nakatani T
Int J Mol Med; 2003 Dec; 12(6):861-5. PubMed ID: 14612958
[TBL] [Abstract][Full Text] [Related]
23. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of human chondrosarcoma cell growth via apoptosis by peroxisome proliferator-activated receptor-gamma.
Nishida K; Furumatsu T; Takada I; Kawai A; Yoshida A; Kunisada T; Inoue H
Br J Cancer; 2002 Apr; 86(8):1303-9. PubMed ID: 11953889
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; Iñiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
26. 15-Deoxy-delta12,14-prostaglandin J2, a ligand for peroxisome proliferators-activated receptor-gamma, induces apoptosis in human hepatoma cells.
Date M; Fukuchi K; Morita S; Takahashi H; Ohura K
Liver Int; 2003 Dec; 23(6):460-6. PubMed ID: 14986820
[TBL] [Abstract][Full Text] [Related]
27. [Apoptosis of human lung cancer cells induced by activated peroxisome proliferator-activated receptor-gamma and its mechanism].
Zhang M; Zou P; Bai M; Tao XN; Jin Y; Guo R
Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1169-72. PubMed ID: 12921638
[TBL] [Abstract][Full Text] [Related]
28. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
Katiyar SK; Meeran SM; Katiyar N; Akhtar S
Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128
[TBL] [Abstract][Full Text] [Related]
29. Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibition.
Avis I; Martínez A; Tauler J; Zudaire E; Mayburd A; Abu-Ghazaleh R; Ondrey F; Mulshine JL
Cancer Res; 2005 May; 65(10):4181-90. PubMed ID: 15899809
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
Farrajota K; Cheng S; Martel-Pelletier J; Afif H; Pelletier JP; Li X; Ranger P; Fahmi H
Arthritis Rheum; 2005 Jan; 52(1):94-104. PubMed ID: 15641079
[TBL] [Abstract][Full Text] [Related]
31. EGR1 expression: a calcium and ERK1/2 mediated PPARγ-independent event involved in the antiproliferative effect of 15-deoxy-Δ12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells.
Chbicheb S; Yao X; Rodeau JL; Salamone S; Boisbrun M; Thiel G; Spohn D; Grillier-Vuissoz I; Chapleur Y; Flament S; Mazerbourg S
Biochem Pharmacol; 2011 May; 81(9):1087-97. PubMed ID: 21338579
[TBL] [Abstract][Full Text] [Related]
32. Involvement of c-jun N-terminal kinase activation in 15-deoxy-delta12,14-prostaglandin J2-and prostaglandin A1-induced apoptosis in AGS gastric epithelial cells.
Liu JD; Lin SY; Ho YS; Pan S; Hung LF; Tsai SH; Lin JK; Liang YC
Mol Carcinog; 2003 May; 37(1):16-24. PubMed ID: 12720296
[TBL] [Abstract][Full Text] [Related]
33. Ligands for peroxisome proliferator-activated receptor gamma have potent antitumor effect against human renal cell carcinoma.
Yuan J; Takahashi A; Masumori N; Uchida K; Hisasue S; Kitamura H; Itoh N; Tsukamoto T
Urology; 2005 Mar; 65(3):594-9. PubMed ID: 15780399
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of antitumor activity of docetaxel by celecoxib in lung tumors.
Shaik MS; Chatterjee A; Jackson T; Singh M
Int J Cancer; 2006 Jan; 118(2):396-404. PubMed ID: 16052515
[TBL] [Abstract][Full Text] [Related]
35. Nanomolar and micromolar effects of 15-deoxy-delta 12,14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferator-activated receptors gamma and delta and nuclear factor kappa B.
Berry EB; Keelan JA; Helliwell RJ; Gilmour RS; Mitchell MD
Mol Pharmacol; 2005 Jul; 68(1):169-78. PubMed ID: 15821150
[TBL] [Abstract][Full Text] [Related]
36. Loss of XIAP sensitizes colon cancer cells to PPARgamma independent antitumor effects of troglitazone and 15-PGJ2.
Qiao L; Dai Y; Gu Q; Chan KW; Ma J; Lan HY; Zou B; Rocken C; Ebert MP; Wong BC
Cancer Lett; 2008 Sep; 268(2):260-71. PubMed ID: 18477501
[TBL] [Abstract][Full Text] [Related]
37. Human multiple myeloma cells express peroxisome proliferator-activated receptor gamma and undergo apoptosis upon exposure to PPARgamma ligands.
Ray DM; Bernstein SH; Phipps RP
Clin Immunol; 2004 Nov; 113(2):203-13. PubMed ID: 15451478
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of docetaxel anticancer activity by a novel diindolylmethane compound in human non-small cell lung cancer.
Ichite N; Chougule MB; Jackson T; Fulzele SV; Safe S; Singh M
Clin Cancer Res; 2009 Jan; 15(2):543-52. PubMed ID: 19147759
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis.
Tsubouchi Y; Sano H; Kawahito Y; Mukai S; Yamada R; Kohno M; Inoue K; Hla T; Kondo M
Biochem Biophys Res Commun; 2000 Apr; 270(2):400-5. PubMed ID: 10753637
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2.
Ji JD; Kim HJ; Rho YH; Choi SJ; Lee YH; Cheon HJ; Sohn J; Song GG
Rheumatology (Oxford); 2005 Aug; 44(8):983-8. PubMed ID: 15840591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
